NF-kappaB as a molecular target in the therapy of pancreatic carcinoma.
about
Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancerIn vitro biophysical, microspectroscopic and cytotoxic evaluation of metastatic and non-metastatic cancer cells in responses to anti-cancer drug.Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapyExpression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells.Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo.Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cellsDisclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinoma.Apoptotic pathways in pancreatic ductal adenocarcinomaThe biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB.Cyclin D1 inhibits whereas c-Myc enhances the cytotoxicity of cisplatin in mouse pancreatic cancer cells via regulation of several members of the NF-κB and Bcl-2 families.Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling Pathway.
P2860
Q28477384-EB256FCC-B112-4930-8804-3AB93EE8BD2AQ30694507-D676B7C3-4A4D-4183-A51C-69AEEA710BDDQ33437264-A2B1042F-3EF2-448C-9EDD-2D8AD22AF981Q33643007-E8B622CF-0E6D-477C-B3FB-EC8CD010CA97Q34573492-6CA0893F-FF2C-4E3A-BEF0-0FBD625A3F44Q35486194-1D8CE512-6562-487E-A18C-87D31E788C9EQ35571884-23BDDBF0-259C-4D0A-A04E-B26F593A1C91Q36835642-8FA85876-9128-46BA-9AC6-9E7748F0993EQ37210542-4554E3E9-A650-4FDE-B834-C1C0990F3608Q37392942-5EDE615A-1CD6-4EC1-AC0F-F7F0D5C5B593Q38351517-E09B513B-4895-4AB0-A8EE-7DF9999953D0Q39931378-D4CDD260-3E6D-448F-A383-0C83A80B002DQ41815302-7254EBFC-D5F3-4856-A150-60F56728E09C
P2860
NF-kappaB as a molecular target in the therapy of pancreatic carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NF-kappaB as a molecular target in the therapy of pancreatic carcinoma.
@en
NF-kappaB as a molecular target in the therapy of pancreatic carcinoma.
@nl
type
label
NF-kappaB as a molecular target in the therapy of pancreatic carcinoma.
@en
NF-kappaB as a molecular target in the therapy of pancreatic carcinoma.
@nl
prefLabel
NF-kappaB as a molecular target in the therapy of pancreatic carcinoma.
@en
NF-kappaB as a molecular target in the therapy of pancreatic carcinoma.
@nl
P1476
NF-kappaB as a molecular target in the therapy of pancreatic carcinoma
@en
P2093
P304
P356
10.1007/978-3-540-71279-4_17
P577
2008-01-01T00:00:00Z